Menu 
Global Site
Australia
Canada
China
Germany 
India
Netherlands
New Zealand
Romania 
Russia
South Africa
Spain
Ukraine
United Kingdom 
United States
Brazil
Our Story
Brand
Heritage
Our Founder
Milestones
An Unfinished Agenda
Leadership
Board Of Directors
Management Council 
Featured Stories
Our Products
Business Porfolio
Generics
Over-the-counter
Biologics
Differentiated Formulations
Services (CPS)
APIs
Quality
Therapeutic Focus
Our Science
Research Philosophy
Development Streams
Generics
APIs
Biologics
Proprietary Products
Capabilities
Our People
Humans of Dr. Reddy’s
Our  Citizenship
Patients
Healthcare Professionals
Community
Our Approach
Education
Livelihoods 
Healthcare
Change Makers
Planet
Commitment to the Planet
Initiatives
Carbon Footprint
Affiliates
Dr Reddy’s Foundations 
Partners
Sustainability 
Investors
Reports and Filings 
Annual Reports
Quarterly Reports
SEC Filings
34
th
 Annual General Meeting 
AGM Voting Results
MoA and AoA
Presentations 
Presentations
Earnings Call
Shares
Share Price
Stock Updates
Equity & Dividend History
Unpaid & Unclaimed Dividend
Analyst Coverage
Shareholding Pattern
Share Transfer Information
Buyback
Details of Shares for transfer to IEPF August 17
Notice pursuant to IEPF Rules, Aug 17
Details of Shares for transfer to IEPF May 2018
Notice pursuant to IEPF Rules, May 2018
Governance
Internal Control Systems
Committees of the Board
Code of Business Conduct and Ethics (COBE)
Ombudsperson Policy
Supplier Code of Conduct 
Compliance with NYSE
Information to Stakeholders
 Corporate Governance Reports
Policies and Documents
Data Privacy Notice
Investor Services
Statutory Communication
Shareholder’s Contacts 
Shareholder Information
Investor Meeting Details 
Other Stock Exchange Intimations
Media
Press Releases
Media Kit
Dr. Reddy's in the news
Partners
Prospective Partners 
Post an Enquiry
Login for Current Partners
Canada
Dr. Reddy's in Canada 
Our Products
Medical Information
Patient Care Program
Customer Service
Contact Us
Australia
Dr. Reddy's in Australia
Our Products
Our Programmes
Contact Us
Germany 
Dr. Reddy's in Germany 
Our Products
CONTACT Us
India
Portfolio
Top Brands
Biosimilars 
Differentiated Products
OTC List
Therapy Areas
Programs
For Doctors
For Patients
DRFHE
People
Careers
Medical Information
Contact Us
New Zealand
Dr. Reddy's in New Zealand
Contact Us
China
Contact Us
Our Products
Dr. Reddy's in China
Netherlands
Dr. Reddy’s Research and Development 
Contact Us
Contact Us
Global Locations 
Key Contacts
Medical Information
Bringing expensive medicines within reach
Know More
Know More
Leveraging deep science for breaking
 new ground in cancer treatment
Know More
Accelerating access to high quality 
and affordable biosimilars
Know More
Our 
 Story
Our 
 Products
Our 
 People
Our 
 Science
Our 
 World
Earnings Call Transcript – Q2 FY19
 | 
Earnings Call Audio - Q2 FY 19 
 | 
Q2 FY19: Financial Performance Press Release
Our Story
Our Brand
Our Heritage
Leadership
Featured Stories
Our Products
Business Focus
Quality
Therapeutic Focus
Our Science
Research Philosophy
Development Streams
Capabilities
Our People
Humans of Dr. Reddy’s
Our  Citizenship
Patients
Healthcare Professionals
Community
Planet
Affiliates
Sustainability
Investors
Media
Partners
Contact Us
© 2018 Dr. Reddy’s Laboratories Ltd. All rights reserved.
Please read the legal notice for further details. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Dr. Reddys Laboratories its subsidiaries or affiliates.
CPSIA Declaration | 
California Compliance | 
Privacy policy | 
Terms Of Use 
| Accessibility